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Background: Liver ischemic insults are important sources of liver injuries 
leading to production of reactive oxygen species (ROS) and mediating liver cell 
injury. Glutathione mediated mechanisms are among the most important 
defense mechanisms of the liver; N-acetylcysteine (NAC) provides cysteine for 
glutathione defense mechanisms. Patients undergoing cardiac surgery are at 
increased risk of liver ischemia. This study was performed to assess the role of 
NAC in prevention of liver ischemia. 
Materials and Methods: In a double blind, randomized clinical trial, 90 
patients entered the study in two groups (45 in each). Patients in the NAC 
group received 150 mg/Kg NAC after induction of anesthesia and the other 
group, the same volume of placebo. Serum levels of aspartate aminotransferase 
(AST), Alanine aminotransferase (ALT) and bilirubin were checked before 
and after the surgery. ANOVA was used for data analysis and p value less than 
0.05 was considered statistically significant. 
Results: No difference between the two groups regarding basic variables; 
however, the postoperative values of AST and ALT were lower in the NAC 
group with statistically significant difference. Also, postoperative levels of 
total bilirubin were lower in the NAC group compared with the control group; 
a statistically significant difference. 
Conclusion: Patients undergoing CABG are advised to receive prophylactic 
150 mg/Kg NAC to improve their postoperative levels of AST, ALT and 
bilirubin. 
Keywords: glutathione antioxidant mechanism, N-acetylcysteine; Aspartate 
aminotransferase (AST), Alanine aminotransferase (ALT), bilirubin, liver 
ischemia. 
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Liver ischemic insults are important source of 
liver injuries; mainly through inflammatory pathways 
and oxidative stress chain of injury which leads to 
production of reactive oxygen species (ROS); these 
ROS's mediate endoplasmic reticulum stress response 
leading to liver cell injury (1-4). One of the most 
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important defense mechanisms that is used by liver is 
the glutathione mediated mechanisms; N-
acetylcysteine (NAC) provides cysteine for defense 
mechanisms exerted by glutathione (2, 5-9). NAC has 
similar structure with cysteine (Figure 1), being an 
appropriate lysine releasing agent which supports the 
glutathione mediated protective mechanisms (10). 
Patients undergoing cardiac surgery with 
cardiopulmonary bypass (CPB) are at increased risk of 
mesenteric ischemia. Many strategies have been used 
for organ protection in these groups of patients; 
however, some controversies exist. Among the organs 
at risk of ischemia is the liver; this is why liver 
protection is always at the top list of organs aimed to 
be protected in such patients. Serum levels of Aspartate 
aminotransferase i.e. AST (formerly known as SGOT) 
and Alanine aminotransferase i.e. ALT (formerly 
known as SGPT) are still among the very sensitive and 
predictive biomarkers of liver injury. 
The effects of NAC on organ protection have 
been studied in a number of organs (11-15); however, 
assessment of NAC effects on liver function in CABG 
patients has not been studied yet. So, this randomized 
clinical trial was designed and performed to assess the 
role of NAC in prevention of liver ischemia monitored 
by serum levels of Aspartate aminotransferase i.e. AST 
(formerly known as SGOT), Alanine aminotransferase 
(formerly known as SGPT) and total bilirubin before 
and after CABG with CPB. 
 
Methods 
The research project was approved by the 
ethics committee on research studies, School of 
Medicine, SBMU, Tehran, Iran; Numbered M-540 and 
dated January 17, 2015. 
The main goal of the study was to assess the 
effects of NAC on liver function test after CABG with 
CPB; however, the subordinate goals were measuring 
liver function tests in the NAC group before and after 
CABG with CPB and comparing with liver function 
tests in the control group.  
Among the total of patients entered the cardiac 
operation room in Modarres hospital, Tehran, Iran, for 
CABG with CPB in 2015, a total of 90 patients were 
selected based on inclusion and exclusion criteria.  
Inclusion criteria for the study were: Elective 
CABG using CPB, Age 30-65 years, Heart failure was 
ruled out (right sided or left sided, including low left 
ventricular ejection fraction, i.e. preoperative 
LVEF<25%), Normal renal function, Normal hepatic 
function, Diabetes mellitus was ruled out, Treated or 
controlled hypertension, Treated or controlled thyroid 
status, Treated or controlled rhythm disorders, Treated 
or controlled hepatic status, History of drug or 
substance abuse was ruled out. 
And exclusion criteria were: Emergent or 
urgent progress of disease after primary allocation, 
Patient refusal to continue study, Newly administered 
steroids, anti-inflammatory agents or anticonvulsants 
or other drugs affecting liver function. 
Sample size determination was done after a 
power analysis: power= 0.8; β= 0.2; α= 0.02, using 
sample size software (PASS 2005, NCSS LLC, 
Kaysville, Utah, USA). Then, using this equation: n= 
2[(Zβ+Zα) σ/Δ]2 and considering the following items, 
the final sample size in each group was 44 which was 
rounded to 45 in each group (16, 17): 
• Zα= 1.96 
• Zβ= 0.84 
• σ (estimated standard deviation based on similar 
studies) = 5 
• Δ= the estimated effect size (i.e. the minimal 
difference desired between the two study interventions 
or the clinical outcomes of the two groups)= 3 
 
Figure 1. N Acetylcysteine (NAC) molecule. 
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The sample size (i.e. 90 study patients) was 
randomly assigned into two study groups using the 
table of random numbers (simple randomization). And 
all continuous data with normal distribution were 
expressed as mean±SD. 
All the patients entered the operating room 
after a primary anesthesia visit and also, a blood 
sampling to assess baseline serum levels of AST, ALT 
and bilirubin. The anesthesia method, the surgeon and 
the cardiopulmonary bypass protocol was planned to 
be as similar as possible. Total bypass time and aortic 
cross clamp time, also, baseline patient characteristics 
were recorded. The AC group received 150 mg/Kg 
NAC through the central line after induction of 
anesthesia and intubation; while the control group 
received the same volume of normal saline as placebo. 
The patients were transferred to the cardiac 
intensive care unit afterwards and then, if they matched 
the extubation criteria, were weaned and extubated. 
Also, ANOVA was used for comparison 
between groups and post-hoc analysis for further 
analysis. Also, Chi-square, and Fisher exact tests were 
used. All statistical analyses were performed by SPSS 
software (Version 11.5, SPSS, Inc, Chicago, IL). 
Meanwhile a P value less than 0.05 was statistically 
considered significant.  
Results 
There was no statistically significant difference 
between the two groups regarding basic variables 
(Table 1). 
The results of liver function tests were 
compared and are demonstrated in Tables 2-4. AST 
levels were not different between the two groups in the 
preoperative period. However, postoperative results 
were significantly different. Post hoc analysis 
demonstrated difference between the groups as 
demonstrated in Table 2 with significantly lower 
postoperative results in the NAC group. 
ALT levels were not different between the two 
groups in the preoperative period. However, 
postoperative results were significantly different. Post 
hoc analysis demonstrated difference between the 
groups as demonstrated in Table 3 with significantly 
lower postoperative results in the NAC group. 
Bilirubin levels were not different between the 
two groups in the preoperative period. However, 
postoperative results were significantly different. Post 
hoc analysis demonstrated difference between the 
groups as demonstrated in Table 4 with significantly 
higher postoperative results in the control group. 
Discussion 
The current study demonstrated improved liver 
function tests in CABG patients with CPB receiving 
NAC compared with the control group. Also, less 
increase in postoperative bilirubin was seen in the 
NAC group. Decreased AST and ALT after CABG in 
the NAC group is remarkably important, leading to real 
outcome improvements in our study; especially in 
patients who are at risk of decreased visceral perfusion 
during the operation (especially during CPB) with real 
risk of ischemia and injury to the liver (1); though in 
other clinical states there are some controversies in 
favor or against NAC (18, 19). However, our findings 
demonstrated that NAC improvement in LFT’s is a 











28/17 30/15 >0.05 
Age 53±8 51±10 >0.05 
Weight 73±11 71±12 >0.05 
LVEF, % 43±7 45±6 >0.05 
CPB time 96±14 93±16 >0.05 
ACC time 51±8 49±9 >0.05 
 
LVEF: left ventricular ejection fraction; CPB: 
cardiopulmonary bypass; ACC: aortic cross clamp 
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very impressive outcome which could help us prevent 
ischemic insults to the liver tissue. This is primarily 
due to the effects of NAC on glutathione system which 
is a liver protective mechanism; however, anti-
inflammatory effects of NAC may have roles; which 
were not studied here. 
These results were in concordance with other 
studies assessing the effect of NAC on lung function 
(10-13, 20, 21); these researches have demonstrated 
the antioxidant and anti-inflammatory role of NAC in 
organ protection in many organ systems including 
liver; a finding in concordance with our results (22). 
On the other hand, the results of this study were in 
concordance with other studies that have assessed the 
effects of NAC on liver function. Most of the studies 
assessing the role of NAC on liver function deal with 
the role of NAC on liver protection during drug 
induced liver injury (DILI) especially due to 
acetaminophen overdose (19, 23-25). However, there 
are studies assessing the protective effects of NAC 
during anesthesia, both in liver transplant and other 
surgical procedures under general anesthesia; which 
are in favor of improved liver function with 
administration of NAC (26-28). 
Based on our study, patients undergoing CABG 
are advised to receive prophylactic NAC to improve 
their postoperative levels of AST, ALT and bilirubin.  
The lab tests in this study are both sensitive and 
specific; however, some studies have used micro RNA 
assays for assessment of liver function; which assess 
cellular mechanisms of liver function; so, if we could 
use these tests, our study could be much more valuable; 
however, we could not use such techniques in our 
patients. 
Conclusion 
On the other hand, anti-inflammatory effects of 
NAC were not assessed in our study; if they were 
Table 2:AST levels (SGOT) in the two groups. 






28±8 * 30±9 
Postoperative 
AST 
19±6 * 38±14 * 
 
 
* P value=0.01; post hoc analysis demonstrated difference 
between the groups with asteroid  
Table 3:ALT levels (SGPT) in the two groups. 








32±9 * 31±10 
Postoperative 
ALT 
21±7 * 40±12 * 
 
* P value=0.01; post hoc analysis demonstrated difference 
between the groups with asteroid  













0.71±0.06 1.02±1.1 * 
 
* P value=0.03; post hoc analysis demonstrated difference 
between the groups with asteroid  
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measured, they could help us detect the anti-
inflammatory effects of NAC on liver function in these 
patients. 
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